BHC: BauschHealth?Companies?Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8,169.09
Enterprise Value ($M) 31,974.50
Book Value ($M) 2,693.00
Book Value / Share 7.65
Price / Book 3.02
NCAV ($M) -25,497.00
NCAV / Share -72.46
Price / NCAV -0.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 0.83
Current Ratio 1.08

Balance Sheet (mrq) ($M)
Current Assets 4,275.00
Assets 32,551.00
Liabilities 29,772.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -2,384.00
Net Income -4,144.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted -11.81
Earnings Per Share Basic -11.81

Cash Flow Statement (mra) ($M)
Cash From Operations 1,501.00
Cash from Investing -196.00
Cash from Financing -196.00

Source:
Fintel.io
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-08-06 10-Q BHC / BauschHealth?Companies?Inc. 10-Q – Quarterly Report – BHC Q2 2019 FORM 10-Q
2019-05-06 10-Q BHC / BauschHealth?Companies?Inc. 10-Q Quarterly Report BHC Q1 2019 FORM 10-Q
2019-02-20 10-K BHC / BauschHealth?Companies?Inc. 10-K (Annual Report)
2018-11-06 10-Q BHC / BauschHealth?Companies?Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
ABT – Abbott Laboratories AGN – Allergan plc
ALR – Alere Inc. BHS – Bausch Health Companies
BMY – Bristol-Myers Squibb Co.


Financial data and stock pages provided for FREE by
Fintel.io